Skip to content
Recall Observatory FDA recall evidence

Drug product

Minivelle (estradiol transdermal system) 0.0375 mg/day, 1 System per pouch (NDC 68968-6637-1), packaged in 8 pouches per box (NDC 68968-6637-8), Rx only, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186; Dist. by: Noven Therapeutics, LLC, Miami, Florida 33186.

D-0863-2018

May 04, 2018

Class II

Product summary

Firm
Noven Pharmaceuticals, Inc.
Event
Event 80033
Status
Terminated
Classification
Class II
Quantity
70870 boxes
Official record key
drug-enforcement:D-0863-2018

Official wording

Reason: Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Code information: Lot #: 81896, Exp. 03/19; 82264 Exp. 12/18

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.